000 | 01984 a2200625 4500 | ||
---|---|---|---|
005 | 20250514234556.0 | ||
264 | 0 | _c20060301 | |
008 | 200603s 0 0 eng d | ||
022 | _a0969-7128 | ||
024 | 7 |
_a10.1038/sj.gt.3302549 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSondhi, D | |
245 | 0 | 0 |
_aAAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL. _h[electronic resource] |
260 |
_bGene therapy _cNov 2005 |
||
300 |
_a1618-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAminopeptidases |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aDependovirus _xgenetics |
650 | 0 | 4 | _aDipeptidyl-Peptidases and Tripeptidyl-Peptidases |
650 | 0 | 4 |
_aEndopeptidases _xanalysis |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aGenes, Recessive |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 |
_aNeuronal Ceroid-Lipofuscinoses _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 | _aSerine Proteases |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTripeptidyl-Peptidase 1 |
700 | 1 | _aPeterson, D A | |
700 | 1 | _aGiannaris, E L | |
700 | 1 | _aSanders, C T | |
700 | 1 | _aMendez, B S | |
700 | 1 | _aDe, B | |
700 | 1 | _aRostkowski, A B | |
700 | 1 | _aBlanchard, B | |
700 | 1 | _aBjugstad, K | |
700 | 1 | _aSladek, J R | |
700 | 1 | _aRedmond, D E | |
700 | 1 | _aLeopold, P L | |
700 | 1 | _aKaminsky, S M | |
700 | 1 | _aHackett, N R | |
700 | 1 | _aCrystal, R G | |
773 | 0 |
_tGene therapy _gvol. 12 _gno. 22 _gp. 1618-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.gt.3302549 _zAvailable from publisher's website |
999 |
_c15705562 _d15705562 |